Abhishek Maiti Selected Research

Abhishek Maiti Research Topics

Disease

35	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 12/2016
9	Neoplasms (Cancer) 03/2024 - 01/2017
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024 - 01/2019
5	Leukemia 02/2024 - 02/2019
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2018
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2017
3	Infections 01/2022 - 09/2018
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2016
3	Blast Crisis (Blast Phase) 01/2021 - 01/2017
2	Lymphoma (Lymphomas) 07/2022 - 01/2021
2	Cytopenia 01/2022 - 01/2021
2	Philadelphia Chromosome 01/2021 - 01/2020
2	Neutropenia 01/2021 - 02/2019
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 02/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 09/2018
2	Sarcoma (Soft Tissue Sarcoma) 02/2019 - 04/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2017 - 04/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024
1	Bites and Stings (Sting) 04/2023
1	Cytokine Release Syndrome 01/2023
1	Multiple Myeloma 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Invasive Fungal Infections 10/2022
1	Hydroa Vacciniforme 07/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2022
1	Exanthema (Rash) 01/2021
1	Tumor Lysis Syndrome 01/2021
1	Thymoma (Thymic Carcinoma) 06/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 06/2019
1	Acquired amegakaryocytic thrombocytopenia 06/2019
1	Anemia 02/2019
1	Disease Resistance 01/2019
1	Carcinosarcoma 01/2019
1	Sepsis (Septicemia) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019

Drug/Important Bio-Agent (IBA)

27	venetoclaxIBA 04/2024 - 01/2018
9	Decitabine FDA Link 04/2024 - 01/2021
5	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
2	enasidenibIBA 01/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2019
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 11/2022
2	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2022 - 09/2017
2	ibrutinibIBA 01/2020 - 09/2018
2	Gemcitabine FDA Link 01/2019 - 08/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2024
1	Lipid Bilayers (Lipid Bilayer)IBA 03/2024
1	RNA Splicing FactorsIBA 11/2023
1	midostaurinIBA 04/2023
1	gilteritinibIBA 04/2023
1	c-Mer Tyrosine KinaseIBA 04/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	daratumumabIBA 01/2023
1	EnzymesIBA 01/2023
1	NucleophosminIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	NivolumabIBA 01/2023
1	MethyltransferasesIBA 01/2023
1	AntibodiesIBA 01/2023
1	EpitopesIBA 01/2023
1	TriazolesIBA 10/2022
1	Dapsone FDA Link 07/2022
1	romidepsin (FK228)FDA Link 07/2022
1	Thalidomide (Thalomid)FDA Link 07/2022
1	Methotrexate (Mexate)FDA LinkGeneric 07/2022
1	Prednisone (Sone)FDA LinkGeneric 07/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2022
1	purineIBA 05/2022
1	AnthracyclinesIBA 05/2022
1	trametinibIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	bosutinibIBA 01/2021
1	AzolesIBA 01/2021
1	Inotuzumab OzogamicinIBA 01/2021
1	nelarabine (506U78)FDA Link 01/2021
1	bcr-abl Fusion ProteinsIBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	CR 6IBA 01/2020
1	PM 01183IBA 02/2019
1	TrabectedinIBA 02/2019
1	CreatinineIBA 02/2019
1	binimetinibIBA 01/2019
1	eculizumab FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	MitogensIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019

Therapy/Procedure

20	Therapeutics 03/2024 - 01/2017
17	Drug Therapy (Chemotherapy) 12/2023 - 04/2016
2	Hematopoietic Stem Cell Transplantation 02/2024 - 01/2023
2	Induction Chemotherapy 01/2022 - 12/2016
2	Adjuvant Chemotherapy 04/2016 - 01/2013
1	Remission Induction 10/2022
1	Drug Tapering 01/2022
1	Stem Cell Transplantation 06/2019